Johanna House

Johanna House serves as a key procurement lead within the Defense Health Agency, overseeing acquisitions critical to sustaining clinical readiness across the global Department of Defense healthcare system. She specializes in the procurement of in-vitro diagnostic substances and related laboratory technologies, ensuring that military medical facilities maintain access to accurate, reliable, and rapidly deployable diagnostic tools. Her work directly supports the agency’s mission to modernize clinical workflows and secure the pharmaceutical and diagnostic supply chain, with a focus on high-stakes, mission-critical medical products used in operational and garrison settings. Her primary contractor relationships include Dependable On-Site Scan & Shred, Inc., Hanith Biosciences, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc.—all of whom provide specialized diagnostic reagents, laboratory automation systems, and point-of-care testing technologies. These partnerships reflect a pattern of engagement with niche suppliers capable of meeting stringent DoD regulatory and security standards, often requiring validated supply chains and validated sterility or biocontainment protocols. Johanna’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability, regulatory compliance, and supply chain resilience over socioeconomic preferences, prioritizing mission performance and product integrity above socioeconomic targeting. Her domain expertise is narrowly focused on NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—where she procures complex diagnostic kits, molecular assay reagents, and lab-based testing systems used in infectious disease surveillance, trauma care, and force health protection. Her technical acumen ensures that acquisitions align with FDA-cleared and DoD-approved medical standards, supporting the agency’s commitment to clinical quality and operational readiness through advanced diagnostics.